Mastering large-scale mRNA purification - a key to future therapies against SARS-CoV-2

Affinity-based, scalable mRNA purification offers a path towards rapid development of mRNA vaccines and treatments for existing and emerging diseases. Learn how biopharmaceutical companies are leveraging tools like Thermo Scientific POROS Oligo (dT)25 affinity resin to bypass traditional bottlenecks in the production of these critically needed therapeutic solutions.

Complete the form below to download the article entitled - "Get in the mRNA Vaccine Race with Affinity Purification".

* Required field

*
*
*
*
*
*
*
 
 Yes
 No

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.